MIR6862-1

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR6862-1 RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated MIR6862-1 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher MIR6862-1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR6862-1 expression acts as an unfavorable survival marker.

STAD are the cancer types where MIR6862-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
STADOSTertileAll0.2340.691<.00181view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

MIR6862-1–STAD (OS)

Kaplan–Meier survival curve for MIR6862-1 RNA-high vs -low samples in STAD.

Open the STAD breakdown →

Exploration